Mesenchymal stem cells isolated from Wharton's jelly ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04651855 (ClinicalTrials.gov)	December 2, 2020	30/9/2020	The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS	The Evaluation of the Effect of Wharton's Jelly Mesenchymal Stem Cells (WJMSCs) on the Immune System ...	Amyotrophic Lateral Sclerosis	Drug: Mesenchymal stem cells isolated from Wharton's jelly	Polski Bank Komorek Macierzystych JSC (PBKM)	National Center for Research and Development, Poland	Active, not recruiting	18 Years	N/A	All	20	Phase 1/Phase 2	Poland

First Previous1Next Last